Results 101 to 110 of about 801 (188)

Impact of BRCA Alterations on Androgen Receptor Pathway Inhibition Treatment Outcomes in Advanced Prostate Cancer. [PDF]

open access: yesCancer Res Commun
Chaudhary R   +8 more
europepmc   +1 more source

Plain language review: the safety of relugolix combination therapy for advanced prostate cancer. [PDF]

open access: yesFuture Oncol
La Cerda J   +6 more
europepmc   +1 more source

A new polymorph of 2-thiohydantoin

open access: yesA new polymorph of 2-thiohydantoin
A new polymorphic crystal of the title compound, C3H4N2OS, belongs to space group P1 with cell dimensions of a = 4.0520(9)Å, b = 6.550(1)Å, c = 9.170(2)Å, a = 100.148(4)°, b = 100.814(4)°, g = 96.831(4)°, R1= 0.069. Neighboring molecules are connected to form cyclic dimers via two types of hydrogen bonds, one between the thioamide groups and the other ...
openaire   +1 more source

Cancer-control outcomes of patients with metastatic hormone-sensitive prostate cancer and ≥ 10 bone metastases receiving apalutamide: a real-world cohort. [PDF]

open access: yesBMC Cancer
Wenzel M   +12 more
europepmc   +1 more source

A high eosinophil proportion increases the risk of skin-related adverse events induced by apalutamide in patients with prostate cancer. [PDF]

open access: yesFront Immunol
Tasaki Y   +12 more
europepmc   +1 more source

The Therapeutic Potential of Spirooxindoles in Cancer: A Focus on p53-MDM2 Modulation. [PDF]

open access: yesPharmaceuticals (Basel)
Girgis AS   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy